Skip to main content

Rigel Pharmaceuticals Inc 10-Q for FY2021 Q2

Rigel Pharmaceuticals Inc (RIGL)

10-Q 2021-08-03 For: 2021-06-30
View Original
Added on April 06, 2026

About this 10-Q

Rigel Pharmaceuticals Inc filed this 10-Q on August 3, 2021, covering the quarter ended June 30, 2021 (FY2021 Q2).

Headline figures

Quarter ended June 30, 2021, as reported in this filing, compared with the same period a year earlier where the filing states it.

Revenue
$26.27M
up 63.9% from $16.02M a year earlier
Diluted EPS
-$0.08
compared with -$0.10 a year earlier